In a recent clinical trial, tirzepatide achieved 47% greater weight loss compared to semaglutide. More participants lost at least 25% of their initial weight on tirzepatide than on semaglutide.

A blood test that estimates the quantity of sugar attached to your red blood cells. A1C provides an estimate of your average blood sugar level over the past two to three months (expressed as a ...

People with diabetes are at higher risk for developing pneumonia due to impaired immune defenses caused by chronic high blood sugar levels. Vaccination against pneumonia and the flu, among others, is ...

The American Diabetes Association (ADA) recently released their 2025 Standards of Care, which – for the first time – includes recommendations for CGM use in type 2 diabetes, the use of GLP-1 drugs for ...

Early study results found that MariTide, a new potential weight loss drug, showed up to 20% weight loss in people with obesity or overweight, and 17% weight loss with a 2.2% reduction in A1C for ...

Managing diabetes and confronting diabetes stigma around the holidays can be especially challenging and stressful. Consider some simple adjustments – like making recipe swaps and incorporating time in ...

People with diabetes are two to three times as likely to have depression than people without, and that depression often goes underdiagnosed. Acceptance and Commitment Therapy (ACT) is a behavioral ...

Why is this study important? This study will evaluate the effects of different doses of MariTide, an experimental once monthly injectable medication, in people with type 2 diabetes. Early results from ...

What is the aim of the study? This phase 3 trial is studying the effects of Renal Autologous Cell Therapy (REACT) injections on eGFR, a measure of kidney function, in adults with a diagnosis of both ...

U.S. Senator Bernie Sanders reprimanded the FDA for failing to address the rising diabetes and obesity crisis with urgency and action. All parties agreed on the need to combat diabetes and obesity as ...

A class of glucose-lowering drugs that cause the kidneys to excrete excess glucose through the urine. SGLT-2 inhibitors have also been shown to benefit the heart and kidneys in people with and without ...

Time in range is the percentage of time that a person spends with their blood glucose levels in a target range. The range will vary depending on the person, but general guidelines suggest a range of ...